Efficacy and safety of remibrutinib, a Bruton's tyrosine kinase inhibitor, for individuals with IgE-mediated peanut allergy

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Robert A. Wood, Ricardo Tan, Rachna Shah, Bruno Cenni, Ruizhu Huang, Joan H. Dunlop, Monica Ligueros‐Saylan, Daniel F. Soteres

DOI: 10.1016/j.jaci.2025.12.569

Cited by: 0

Fields of Study & Subjects

Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Drug-Induced Adverse Reactions